$2.35 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 105 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 36.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Buy | HORIZON PHARMA PLC | $227,676,000 | -10.1% | 13,740,261 | +17.6% | 9.69% | -5.5% |
| MYL | Buy | MYLAN N V | $84,938,000 | +48.8% | 1,832,535 | +73.5% | 3.62% | +56.3% |
| NXTM | Buy | NXSTAGE MEDICAL INC | $82,535,000 | -17.9% | 5,506,028 | +20.0% | 3.51% | -13.8% |
| Buy | HEALTHWAYS INCnote 1.500% 7/0 | $70,595,000 | +43.8% | 76,925,000 | +48.1% | 3.01% | +51.1% | |
| New | HORIZON PHARMA INVT LTDnote 2.500% 3/1 | $70,475,000 | – | 82,600,000 | +100.0% | 3.00% | – | |
| GSK | GLAXOSMITHKLINE PLCsponsored adr | $67,937,000 | +0.5% | 1,675,385 | 0.0% | 2.89% | +5.6% | |
| AET | AETNA INC NEW | $66,451,000 | +3.9% | 591,465 | 0.0% | 2.83% | +9.1% | |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $63,032,000 | +79.2% | 3,089,785 | +351.9% | 2.68% | +88.2% |
| AVXS | New | AVEXIS INC | $60,928,000 | – | 2,236,701 | +100.0% | 2.59% | – |
| DVA | DAVITA HEALTHCARE PARTNERS I | $60,318,000 | +5.3% | 822,000 | 0.0% | 2.57% | +10.6% | |
| EDIT | New | EDITAS MEDICINE INC | $59,043,000 | – | 1,709,400 | +100.0% | 2.51% | – |
| ADPTQ | Sell | ADEPTUS HEALTH INCcl a | $53,126,000 | -25.5% | 956,533 | -26.9% | 2.26% | -21.7% |
| XNPT | Buy | XENOPORT INC | $52,190,000 | +51.2% | 11,572,125 | +84.1% | 2.22% | +58.8% |
| VNDA | VANDA PHARMACEUTICALS INC | $50,132,000 | -10.2% | 5,996,691 | 0.0% | 2.13% | -5.7% | |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $48,656,000 | +125.9% | 674,373 | +117.5% | 2.07% | +137.3% |
| XNCR | Buy | XENCOR INC | $46,534,000 | +153.3% | 3,467,512 | +175.9% | 1.98% | +165.9% |
| AACH | Buy | AAC HLDGS INC | $45,417,000 | +33.7% | 2,294,936 | +28.8% | 1.93% | +40.5% |
| FLML | FLAMEL TECHNOLOGIES SAsponsored adr | $44,964,000 | -9.6% | 4,072,809 | 0.0% | 1.91% | -5.0% | |
| WBA | Buy | WALGREENS BOOTS ALLIANCE INC | $43,085,000 | +30.9% | 511,457 | +32.3% | 1.83% | +37.5% |
| Buy | ENDOLOGIX INCnote 3.250%11/0 | $38,632,000 | +18.7% | 40,000,000 | +33.3% | 1.64% | +24.7% | |
| UAM | Buy | UNIVERSAL AMERN CORP NEW | $37,738,000 | +12.6% | 5,285,500 | +10.4% | 1.61% | +18.2% |
| HEARTWARE INTL INCnote 3.500%12/1 | $36,498,000 | -2.3% | 39,226,000 | 0.0% | 1.55% | +2.6% | ||
| New | WRIGHT MED GROUP INCnote 2.000% 2/1 | $35,961,000 | – | 40,050,000 | +100.0% | 1.53% | – | |
| ARRAY BIOPHARMA INCnote 3.000% 6/0 | $35,876,000 | -15.2% | 45,000,000 | 0.0% | 1.53% | -10.9% | ||
| SAGE | Buy | SAGE THERAPEUTICS INC | $35,704,000 | +2.3% | 1,113,654 | +86.0% | 1.52% | +7.4% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $32,011,000 | +62.7% | 2,632,482 | +225.9% | 1.36% | +71.0% |
| EHTH | EHEALTH INC | $30,654,000 | -5.9% | 3,264,588 | 0.0% | 1.30% | -1.1% | |
| ZLTQ | New | ZELTIQ AESTHETICS INC | $29,996,000 | – | 1,104,417 | +100.0% | 1.28% | – |
| ENDOLOGIX INCnote 2.250%12/1 | $29,871,000 | -13.7% | 40,941,000 | 0.0% | 1.27% | -9.3% | ||
| ARRY | Buy | ARRAY BIOPHARMA INC | $28,112,000 | -23.7% | 9,529,361 | +9.2% | 1.20% | -19.8% |
| FPRX | FIVE PRIME THERAPEUTICS INC | $27,628,000 | -2.1% | 680,000 | 0.0% | 1.18% | +2.8% | |
| MCK | Buy | MCKESSON CORP | $27,519,000 | -3.5% | 175,000 | +21.0% | 1.17% | +1.4% |
| HTWR | Buy | HEARTWARE INTL INC | $27,355,000 | +239.3% | 870,634 | +444.3% | 1.16% | +256.3% |
| ACOR | New | ACORDA THERAPEUTICS INC | $27,228,000 | – | 1,029,410 | +100.0% | 1.16% | – |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $26,620,000 | +58.7% | 817,806 | +77.1% | 1.13% | +66.6% |
| RLYP | Buy | RELYPSA INC | $25,386,000 | -0.5% | 1,873,471 | +108.1% | 1.08% | +4.5% |
| HWAY | Buy | HEALTHWAYS INC | $24,977,000 | -21.3% | 2,475,387 | +0.4% | 1.06% | -17.3% |
| SPECTRANETICS CORPmtnf 2.625% 6/0 | $23,643,000 | +4.9% | 29,831,000 | 0.0% | 1.01% | +10.3% | ||
| INFI | Buy | INFINITY PHARMACEUTICALS INC | $23,182,000 | -31.4% | 4,398,862 | +2.2% | 0.99% | -28.0% |
| KMPH | KEMPHARM INC | $20,597,000 | -27.0% | 1,420,497 | 0.0% | 0.88% | -23.3% | |
| ZFGN | Buy | ZAFGEN INC | $20,411,000 | +284.6% | 3,055,603 | +262.2% | 0.87% | +304.2% |
| DNAI | Buy | PRONAI THERAPEUTICS INC | $20,229,000 | -24.9% | 3,001,302 | +67.6% | 0.86% | -21.2% |
| RAD | Sell | RITE AID CORP | $19,504,000 | -0.2% | 2,393,072 | -4.0% | 0.83% | +4.8% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $18,934,000 | -49.7% | 1,193,811 | +2.6% | 0.81% | -47.1% |
| AXGN | AXOGEN INC | $18,125,000 | +7.2% | 3,381,439 | 0.0% | 0.77% | +12.7% | |
| AKTX | AKARI THERAPEUTICS PLCsponsored adr | $16,110,000 | -3.4% | 1,150,700 | 0.0% | 0.69% | +1.5% | |
| NVLS | NIVALIS THERAPEUTICS INC | $15,564,000 | -46.1% | 3,732,412 | 0.0% | 0.66% | -43.4% | |
| FLUIDIGM CORP DELnote 2.750% 2/0 | $15,353,000 | -12.8% | 27,715,000 | 0.0% | 0.65% | -8.3% | ||
| ANTM | Buy | ANTHEM INC | $14,177,000 | +593.9% | 102,000 | +596.3% | 0.60% | +627.7% |
| GLPG | Buy | GALAPAGOS NVspon adr | $13,701,000 | +19.1% | 327,626 | +79.0% | 0.58% | +25.1% |
| NVAX | New | NOVAVAX INC | $12,674,000 | – | 2,456,261 | +100.0% | 0.54% | – |
| RGNX | REGENXBIO INC | $12,626,000 | -34.9% | 1,169,042 | 0.0% | 0.54% | -31.6% | |
| IMPR | Sell | IMPRIVATA INC | $12,420,000 | -8.9% | 983,366 | -18.5% | 0.53% | -4.3% |
| CTMX | Sell | CYTOMX THERAPEUTICS INC | $12,170,000 | -38.4% | 943,433 | -0.3% | 0.52% | -35.2% |
| ALIM | ALIMERA SCIENCES INC | $10,287,000 | -27.7% | 5,878,015 | 0.0% | 0.44% | -24.1% | |
| PRTO | PROTEON THERAPEUTICS INC | $9,794,000 | -50.1% | 1,265,343 | 0.0% | 0.42% | -47.5% | |
| MGNX | MACROGENICS INC | $9,711,000 | -39.5% | 517,920 | 0.0% | 0.41% | -36.5% | |
| IVTY | Buy | INVUITY INC | $9,581,000 | +0.7% | 1,327,009 | +23.1% | 0.41% | +6.0% |
| GI | ENDOCHOICE HLDGS INC | $9,499,000 | -37.6% | 1,823,309 | 0.0% | 0.40% | -34.5% | |
| XLRN | Buy | ACCELERON PHARMA INC | $9,329,000 | -10.4% | 353,491 | +65.6% | 0.40% | -5.9% |
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $9,227,000 | -28.8% | 606,222 | -31.2% | 0.39% | -25.1% |
| Buy | ESSA PHARMA INC | $8,408,000 | -1.1% | 2,587,215 | +39.2% | 0.36% | +4.1% | |
| New | CEPHEIDdbcv 1.250% 2/0 | $6,917,000 | – | 7,750,000 | +100.0% | 0.30% | – | |
| LOXO | LOXO ONCOLOGY INC | $6,862,000 | -3.9% | 251,000 | 0.0% | 0.29% | +1.0% | |
| SEM | New | SELECT MED HLDGS CORP | $6,603,000 | – | 559,097 | +100.0% | 0.28% | – |
| FOMX | FOAMIX PHARMACEUTICALS LTD | $6,187,000 | -19.6% | 948,934 | 0.0% | 0.26% | -15.7% | |
| GNCA | Sell | GENOCEA BIOSCIENCES INC | $6,093,000 | +38.1% | 787,257 | -6.0% | 0.26% | +44.7% |
| ARLZ | New | ARALEZ PHARMACEUTICALS INC | $5,838,000 | – | 1,644,583 | +100.0% | 0.25% | – |
| JAZZ INVESTMENTS I LTDnote 1.875% 8/1 | $5,111,000 | -2.1% | 5,000,000 | 0.0% | 0.22% | +2.8% | ||
| RIGL | RIGEL PHARMACEUTICALS INC | $4,988,000 | -31.4% | 2,397,855 | 0.0% | 0.21% | -27.9% | |
| NEOS | NEOS THERAPEUTICS INC | $4,945,000 | -24.7% | 458,332 | 0.0% | 0.21% | -20.7% | |
| ELGX | New | ENDOLOGIX INC | $4,764,000 | – | 569,895 | +100.0% | 0.20% | – |
| ABMD | New | ABIOMED INC | $4,721,000 | – | 49,797 | +100.0% | 0.20% | – |
| OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $4,604,000 | -23.0% | 464,541 | -10.6% | 0.20% | -19.0% |
| CASM | CAS MED SYS INC | $4,544,000 | -19.8% | 3,200,000 | 0.0% | 0.19% | -16.1% | |
| EGLTQ | Buy | EGALET CORP | $4,096,000 | -22.1% | 597,123 | +25.2% | 0.17% | -18.3% |
| ADHD | ALCOBRA LTD | $4,055,000 | -39.6% | 1,069,914 | 0.0% | 0.17% | -36.4% | |
| MYOK | Sell | MYOKARDIA INC | $4,014,000 | -27.0% | 374,800 | -0.1% | 0.17% | -23.3% |
| PSDV | Buy | PSIVIDA CORP | $4,001,000 | -32.1% | 1,492,824 | +22.2% | 0.17% | -28.9% |
| SCYX | Buy | SCYNEXIS INC | $3,417,000 | -21.0% | 848,000 | +21.8% | 0.14% | -17.1% |
| STDY | STEADYMED LTD | $3,313,000 | -24.5% | 1,346,744 | 0.0% | 0.14% | -20.8% | |
| CATB | CATABASIS PHARMACEUTICALS IN | $3,244,000 | -36.4% | 643,580 | 0.0% | 0.14% | -33.3% | |
| TNXP | TONIX PHARMACEUTICALS HLDG C | $3,170,000 | -68.6% | 1,315,551 | 0.0% | 0.14% | -67.0% | |
| ACUR | ACURA PHARMACEUTICALS INC | $2,903,000 | +13.2% | 1,025,641 | 0.0% | 0.12% | +19.2% | |
| TCON | Sell | TRACON PHARMACEUTICALS INC | $2,776,000 | -38.0% | 397,085 | -18.1% | 0.12% | -35.2% |
| ARDX | New | ARDELYX INC | $2,137,000 | – | 275,000 | +100.0% | 0.09% | – |
| VYGR | VOYAGER THERAPEUTICS INC | $2,054,000 | -60.1% | 235,294 | 0.0% | 0.09% | -58.4% | |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $1,975,000 | -57.8% | 471,259 | -31.8% | 0.08% | -55.8% |
| TRILLIUM THERAPEUTICS INC | $1,594,000 | -26.6% | 172,307 | 0.0% | 0.07% | -22.7% | ||
| AGRX | New | AGILE THERAPEUTICS INC | $1,553,000 | – | 250,000 | +100.0% | 0.07% | – |
| TRUP | Sell | TRUPANION INC | $1,529,000 | -85.3% | 155,236 | -85.4% | 0.06% | -84.5% |
| ATEC | ALPHATEC HOLDINGS INC | $1,196,000 | -20.0% | 4,982,738 | 0.0% | 0.05% | -16.4% | |
| CDNA | CAREDX INC | $1,136,000 | -22.5% | 229,000 | 0.0% | 0.05% | -18.6% | |
| STRM | STREAMLINE HEALTH SOLUTIONS | $935,000 | 0.0% | 662,971 | 0.0% | 0.04% | +5.3% | |
| AGN | New | ALLERGAN PLC | $938,000 | – | 3,500 | +100.0% | 0.04% | – |
| VCYT | Sell | VERACYTE INC | $892,000 | -68.4% | 165,097 | -57.9% | 0.04% | -66.7% |
| CDTX | Sell | CIDARA THERAPEUTICS INC | $873,000 | -57.4% | 68,779 | -42.4% | 0.04% | -55.4% |
| CORSICANTO LTDnote 3.500% 1/1 | $821,000 | -8.9% | 1,000,000 | 0.0% | 0.04% | -5.4% | ||
| PFE | New | PFIZER INC | $741,000 | – | 25,000 | +100.0% | 0.03% | – |
| ALQA | Sell | ALLIQUA BIOMEDICAL INC | $547,000 | -86.4% | 667,246 | -64.5% | 0.02% | -85.9% |
| PTN | Sell | PALATIN TECHNOLOGIES INC | $532,000 | -59.9% | 985,693 | -50.7% | 0.02% | -57.4% |
| WMGI | New | WRIGHT MED GROUP N V | $498,000 | – | 30,000 | +100.0% | 0.02% | – |
| RNVA | Sell | RENNOVA HEALTH INC | $265,000 | -64.9% | 353,933 | -36.7% | 0.01% | -64.5% |
| OCRX | New | OCERA THERAPEUTICS INC | $221,000 | – | 75,293 | +100.0% | 0.01% | – |
| RENNOVA HEALTH INC*w exp 12/30/202 | $51,000 | -82.1% | 645,161 | 0.0% | 0.00% | -83.3% | ||
| POZN | Exit | POZEN INC | $0 | – | -44,583 | -100.0% | -0.01% | – |
| ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -3,000 | -100.0% | -0.01% | – |
| BVX | Exit | BOVIE MEDICAL CORP | $0 | – | -688,229 | -100.0% | -0.06% | – |
| CTIC | Exit | CTI BIOPHARMA CORP | $0 | – | -2,236,832 | -100.0% | -0.11% | – |
| TRIB | Exit | TRINITY BIOTECH PLCspon adr new | $0 | – | -246,000 | -100.0% | -0.12% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -1,073,640 | -100.0% | -0.13% | – |
| GENN | Exit | GENESIS HEALTHCARE INC | $0 | – | -963,564 | -100.0% | -0.14% | – |
| ATRS | Exit | ANTARES PHARMA INC | $0 | – | -3,983,440 | -100.0% | -0.20% | – |
| VSAR | Exit | VERSARTIS INC | $0 | – | -490,503 | -100.0% | -0.25% | – |
| Exit | ALLSCRIPTS HEALTHCARE SOLUTNnote 1.250% 7/0 | $0 | – | -12,400,000 | -100.0% | -0.54% | – | |
| CSII | Exit | CARDIOVASCULAR SYS INC DEL | $0 | – | -1,035,000 | -100.0% | -0.63% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -244,000 | -100.0% | -0.65% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -1,667,000 | -100.0% | -0.73% | – |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF IN | $0 | – | -1,388,000 | -100.0% | -0.74% | – |
| GHDX | Exit | GENOMIC HEALTH INC | $0 | – | -809,432 | -100.0% | -1.16% | – |
| PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -371,000 | -100.0% | -1.16% | – |
| CRL | Exit | CHARLES RIV LABS INTL INC | $0 | – | -377,188 | -100.0% | -1.23% | – |
| Exit | ACCURAY INCnote 3.750% 8/0 | $0 | – | -30,511,000 | -100.0% | -1.25% | – | |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDcall | $0 | – | -550,000 | -100.0% | -1.46% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDadr | $0 | – | -815,000 | -100.0% | -2.17% | – |
| GILD | Exit | GILEAD SCIENCES INCcall | $0 | – | -532,000 | -100.0% | -2.18% | – |
| DYAX | Exit | DYAX CORP | $0 | – | -2,242,073 | -100.0% | -3.42% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.